Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating exercise training with nicotinamide riboside (NR) supplementation to improve fitness in adolescent/young adult hematopoietic cell trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide Riboside (NR) supplement (nicotinamide riboside)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Lymphoblastic Leukemia, Cancer Survivors | Phase 2 | Status: RECRUITING